Home
About
Overview
Sharing Data
ORCID
Help
History (39)
Helping Behavior
Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
San Marino
The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations.
The Brief Case: Dyspnea in a Profoundly Immunocompromised Man.
See All 39 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Brief Case: Dyspnea in a Profoundly Immunocompromised Man.
The Brief Case: Dyspnea in a Profoundly Immunocompromised Man. J Clin Microbiol. 2016 10; 54(10):2410-2.
View in:
PubMed
subject areas
Bronchoscopy
Dyspnea
Humans
Immunocompromised Host
Lung Diseases, Fungal
Male
Microbiological Techniques
Microscopy
Middle Aged
Paecilomyces
Radiography, Thoracic
Tomography, X-Ray Computed
authors with profiles
Carlos Santos